Chester County News and Community Website
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) reported record revenue of $1.44 million for the second quarter of 2024, representing a 23.4% year-over-year increase. The company’s growth was driven significantly …
NEXGEL Announces Record Second Quarter Revenue and Strategic Developments Read More
HORSHAM, PA — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) has announced its financial results for the quarter ended June 30, 2024, along with notable corporate updates.
STRATA Skin Sciences Reports Second Quarter 2024 Financial Results and Strategic Progress Read More
NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (Nasdaq: AVBP) has announced its financial results for the second quarter of 2024, alongside significant advancements in its oncology pipeline and recent corporate …
ArriVent BioPharma Reports Strong Second Quarter and Highlights Progress Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced its financial results this week for the second quarter ended June 30, 2024, reporting net revenue of $4.9 million for …
Verrica Pharmaceuticals Reports Steady Growth with Q2 Financial Results Read More
RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) this week announced its financial results for the second quarter ending June 30, 2024, and provided a corporate update, highlighting significant progress …
Mineralys Therapeutics Posts Q2 Financial Results, Updates on Clinical Trials Read More
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) recently reported its financial results for the second quarter ended June 30, 2024, alongside significant business developments. The company is …
Orchestra BioMed Holdings Reports Second Quarter 2024 Financial Results and Business Updates Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has released its financial and operational results for the second quarter of 2024, marking a period of strategic initiatives and significant developments in …
Neuronetics Reports Second Quarter 2024 Financial Results and Strategic Developments Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has reported its financial results for the second quarter ended June 30, 2024. The company showcased notable revenue growth and significant strategic …
TELA Bio Announces Second Quarter 2024 Financial Results and Strategic Developments Read More
NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq:HSDT) has announced its financial results for the quarter ended June 30, 2024, showcasing significant strides in both financial performance and business development. …
Helius Medical Technologies Reports Second Quarter 2024 Results and Major Milestones Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) has released its financial results for the second quarter ending June 30, 2024, alongside significant business updates that highlight the company’s strategic …
Aprea Therapeutics Reports Second Quarter 2024 Financial Results and Progress in Clinical Trials Read More